These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 32506730)
21. 'Vesicular eruption in COVID-19 - to exclude varicella': reply from the authors. Català A; Galván Casas C; Carretero Hernández G; García-Doval I Br J Dermatol; 2020 Oct; 183(4):791. PubMed ID: 32613623 [No Abstract] [Full Text] [Related]
22. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain. Caselli D; Chironna M; Loconsole D; Nigri L; Mazzotta F; Bonamonte D; Aricò M Br J Dermatol; 2020 Oct; 183(4):784-785. PubMed ID: 32613638 [No Abstract] [Full Text] [Related]
23. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far? Ghazal S; Litvinov IV; Aljahani N; Jfri A; Netchiporouk E J Cutan Med Surg; 2020; 24(4):416-417. PubMed ID: 32391713 [No Abstract] [Full Text] [Related]
25. SARS-CoV-2, COVID-19, skin and immunology - What do we know so far? Novak N; Peng W; Naegeli MC; Galvan C; Kolm-Djamei I; Brüggen C; Cabanillas B; Schmid-Grendelmeier P; Catala A Allergy; 2021 Mar; 76(3):698-713. PubMed ID: 32658359 [TBL] [Abstract][Full Text] [Related]
26. Overlapping findings or oral manifestations in new SARS-CoV-2 infection. Ponce JB; Tjioe KC Oral Dis; 2021 Apr; 27 Suppl 3(Suppl 3):781-782. PubMed ID: 32524689 [No Abstract] [Full Text] [Related]
27. Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations. Garduño-Soto M; Choreño-Parra JA; Cazarin-Barrientos J Arch Dermatol Res; 2021 Oct; 313(8):611-622. PubMed ID: 33159236 [TBL] [Abstract][Full Text] [Related]
28. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles. Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615 [TBL] [Abstract][Full Text] [Related]
29. COVID-19-associated cutaneous manifestations: does human herpesvirus 6 play an aetiological role? Abadías-Granado I; Navarro-Bielsa A; Morales-Callaghan AM; Roc L; Suso-Estívalez CC; Povar-Echeverría M; Gilaberte Y Br J Dermatol; 2021 Jun; 184(6):1187-1190. PubMed ID: 33420720 [No Abstract] [Full Text] [Related]
30. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic? Li H; Zhao Y; Zhou L Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491 [TBL] [Abstract][Full Text] [Related]
31. The Cutaneous Manifestations of COVID-19: A Review of Emerging Literature. Enitan AO; Olasode OA West Afr J Med; 2020 Oct; 37(5):569-573. PubMed ID: 33058134 [TBL] [Abstract][Full Text] [Related]
32. Clinical Patterns and Morphology of COVID-19 Dermatology. Agnihothri R; Fox LP Dermatol Clin; 2021 Oct; 39(4):487-503. PubMed ID: 34556240 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 manifestation in the oral cavity - a narrative literature review. Kusiak A; Cichońska D; Tubaja M; Skorek A; Jereczek-Fossa BA; Corrao G; Marvaso G; Alterio D Acta Otorhinolaryngol Ital; 2021 Oct; 41(5):395-400. PubMed ID: 34734574 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
35. Natural SARS-CoV-2 Infection in Kept Ferrets, Spain. Gortázar C; Barroso-Arévalo S; Ferreras-Colino E; Isla J; de la Fuente G; Rivera B; Domínguez L; de la Fuente J; Sánchez-Vizcaíno JM Emerg Infect Dis; 2021 Jul; 27(7):1994-1996. PubMed ID: 34152974 [TBL] [Abstract][Full Text] [Related]
36. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R; Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group. Larenas-Linnemann D; Luna-Pech J; Navarrete-Rodríguez EM; Rodríguez-Pérez N; Arias-Cruz A; Blandón-Vijil MV; Del Rio-Navarro BE; Estrada-Cardona A; Onuma-Takane E; Pozo-Beltrán CF; Valencia-Herrera AM; Ortiz-Aldana FI; Toledo-Bahena ME Curr Allergy Asthma Rep; 2021 Feb; 21(2):13. PubMed ID: 33630167 [TBL] [Abstract][Full Text] [Related]
38. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient. Santonja C; Heras F; Núñez L; Requena L Br J Dermatol; 2020 Oct; 183(4):778-780. PubMed ID: 32585767 [No Abstract] [Full Text] [Related]
39. Chilblains in children in the setting of COVID-19 pandemic. Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460 [TBL] [Abstract][Full Text] [Related]
40. [RF - Organisation of a Dermatology Department During the COVID-19 Pandemic]. Cerro PA; Palma AM; Navarro-Bielsa A; Gilaberte Y Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):781-782. PubMed ID: 32389322 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]